Koyfin Home > Directory > Health Care > Biogen Inc > Enterprise Value

Biogen Inc Enterprise Value Chart (BIIB)

Biogen Inc annual/quarterly Enterprise Value from 2010 to 2020.
  • Biogen Inc Enterprise Value for the quarter ending November 11, 2020 was $40,744m a 0.15% increase of 62m year over year
  • Biogen Inc Enterprise Value for the last 12 months ending November 11, 2020 was $40,744m a 0.15% increase of 62m year over year
  • Biogen Inc Annual Enterprise Value for 2020 was $40,744m a 0.77% increase of 312m from 2019
  • Biogen Inc Annual Enterprise Value for 2020 was $40,431m a -0.29% decrease of -117m from 2019
  • Biogen Inc Annual Enterprise Value for 2020 was $40,548m a -0.33% decrease of -134m from 2019
Other Valuation Metrics:
  • Biogen Inc Market Cap for the quarter ending June 06, 2018 was $61,243m a -8.10% decrease of -4,961m year over year
  • Biogen Inc Price / Book for the quarter ending June 06, 2018 was 4.36 a -31.13% decrease of -1.36 year over year
View Chart On Koyfin

Quarterly BIIB Enterprise Value Data

11/2020$40,744m
11/2020$40,431m
11/2020$40,548m
11/2020$40,682m
11/2020$40,801m
11/2020$40,779m
11/2020$40,313m
11/2020$41,518m
11/2020$41,849m
11/2020$41,484m

Annual BIIB Enterprise Value Data

2020$40,744m
2020$40,431m
2020$40,548m
2020$40,682m
2020$40,801m
2020$40,779m
2020$40,313m
2020$41,518m
2020$41,849m
2020$41,484m